CIK 0001124105
- Accelerated filer
- Smaller reporting company
GYRE THERAPEUTICS, INC.
Sign in to watch- Ticker
- GYRE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 562020050
- Phone
- +1 858-284-0115
- Business address
- 12730 HIGH BLUFF DRIVE, SUITE 250, SAN DIEGO, CA, 92130
- Former names
- CATALYST BIOSCIENCES, INC., TARGACEPT INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2013-01-17 | Bencherif Merouane SVP and Senior Scien Fellow | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2012-05-18 | Bencherif Merouane SVP, Preclinical Research | Exercise or conversion | +15,938 | $2.93 | $47K | 15,938 |
| 2012-05-18 | Bencherif Merouane SVP, Preclinical Research | Exercise or conversion · Stock Option (Right to Buy) | −15,938 | 7,970 | ||
| 2012-05-04 | Bencherif Merouane SVP, Preclinical Research | Grant or award · Stock Option (Right to Buy) | +90,000 | 90,000 |
Page 1 of 1 · 4 trades